Bone formation in transforming growth factor beta-I-loaded titanium fiber mesh implants.

The osteoconductive properties of porous titanium (Ti) fiber mesh with or without a calcium phosphate (Ca-P) coating and osteoinductive properties of noncoated Ti fiber mesh loaded with recombinant human Transforming Growth Factor beta-1 (rhTGF-beta1) were investigated in a rabbit non-critical size cranial defect model. Nine Ca-P-coated and 18 non-coated porous titanium implants, half of them loaded with rhTGF-beta1, were bilaterally placed in the cranium of 18 New Zealand White rabbits. At 8 weeks postoperative, the rabbits were sacrificed and the skulls with the implants were retrieved. Histological analysis demonstrated that in the TGF-beta1-loaded implants, bone had been formed throughout the implant, up to its center, whereas in the non-loaded implants only partial ingrowth of bone was observed. Bone formation had a trabecular appearance together with bone marrow-like tissue. No difference in ingrowth could be observed between the non-TGF-beta1-loaded non-coated implants and the Ca-P-coated ones. All histological findings were confirmed by image analysis: 97% ingrowth was seen in the rhTGF-beta1-loaded implants, while only 57% and 54% ingrowth was observed in the non-loaded Ca-P-coated and non-coated implants, respectively. Bone surface area and bone fill were significantly higher in the rhTGF-beta1-loaded implants (1.37 mm2 and 36%, respectively) than in the non-loaded implants (0.57 mm2 and 26%). No statistical difference was found for any parameter between the Ca-P-coated and noncoated implants. Quadruple fluorochrome labeling showed that in the Ti and Ti-CaP implants mainly bone guidance had occurred from the former defect edge, while in the Ti-TGF-beta1 implants bone formation had mainly started in the center of a pore and proceeded in a centrifugal manner. Our results show that: (1) the combination of Timesh with TGF-beta1 can induce orthotopic bone formation; (2) Ti-fiber mesh has good osteoconductive properties; (3) a thin Ca-P coating, as applied in this study, does not seem to further enhance the bone-conducting properties of a titanium scaffold material.

[1]  É. Arnaud,et al.  Potentiation of transforming growth factor (TGF-β1) by natural coral and fibrin in a rabbit cranioplasty model , 1994, Calcified Tissue International.

[2]  C. Bünger,et al.  Transforming growth factor-beta 1 stimulates bone ongrowth to weight-loaded tricalcium phosphate coated implants: an experimental study in dogs. , 1996, The Journal of bone and joint surgery. British volume.

[3]  J. Jansen,et al.  A histological evaluation of TiO2-gritblasted and Ca-P magnetron sputter coated implants placed into the trabecular bone of the goat: Part 2. , 2000, Clinical oral implants research.

[4]  P. Puolakkainen,et al.  Stimulation of bone healing by transforming growth factor-beta 1 released from polymeric or ceramic implants. , 1994, Journal of applied biomaterials : an official journal of the Society for Biomaterials.

[5]  J. Ranchalis,et al.  Controlled release of TGF-β1 from a biodegradable matrix for bone regeneration , 1994 .

[6]  M. Noda,et al.  In vivo stimulation of bone formation by transforming growth factor-beta. , 1989, Endocrinology.

[7]  W. Larrabee,et al.  Mandibular Reconstruction With Transforming Growth Factor‐β1 , 1998 .

[8]  A. Bruce,et al.  Transforming growth factor-beta 1 in a guanidine-extracted demineralized bone matrix carrier rapidly closes a rabbit critical calvarial defect. , 1996, The Journal of otolaryngology.

[9]  S. Thorgeirsson,et al.  Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[10]  B. Melsen,et al.  Limited chondro‐osteogenesis by recombinant human transforming growth factor‐β1 in calvarial defects of adult baboons (papio ursinus) , 1996 .

[11]  J. Jansen,et al.  Bone formation in calcium-phosphate-coated titanium mesh. , 2000, Biomaterials.

[12]  C. Klein,et al.  A simple method for preparing thin (10 microM) histological sections of undecalcified plastic embedded bone with implants. , 1988, Stain technology.

[13]  C. Bünger,et al.  Transforming growth factor‐β1 enhances bone healing to unloaded tricalcium phosphate coated implants: An experimental study in dogs , 1996, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[14]  N Muthukumaran,et al.  Isolation of osteogenin, an extracellular matrix-associated, bone-inductive protein, by heparin affinity chromatography. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[15]  L. Deguzman,et al.  Combination of bone marrow and TGF-beta1 augment the healing of critical-sized bone defects. , 1998, Journal of pharmaceutical sciences.

[16]  J. Hollinger,et al.  A Bone Regeneration Study: Transforming Growth Factor‐β1 and Its Delivery , 1996 .

[17]  E. Amento,et al.  Rapid publication TGF‐β1 induces bone closure of skull defects , 1991 .

[18]  Tue Nguyen,et al.  TGF‐β1 induces bone closure of skull defects: Temporal dynamics of bone formation in defects exposed to rhTGF‐β1 , 1993 .

[19]  C. Bünger,et al.  Transforming growth factor-beta stimulates bone ongrowth. Hydroxyapatite-coated implants studied in dogs. , 1996, Acta orthopaedica Scandinavica.

[20]  H. Ohgushi,et al.  BMP-induced osteogenesis on the surface of hydroxyapatite with geometrically feasible and nonfeasible structures: topology of osteogenesis. , 1998, Journal of biomedical materials research.

[21]  J. Jansen,et al.  Evaluation of plasma-spray and magnetron-sputter Ca-P-coated implants: an in vivo experiment using rabbits. , 1996, Journal of biomedical materials research.

[22]  M E Bolander,et al.  Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur , 1990, The Journal of cell biology.

[23]  G Osaka,et al.  Development of tricalcium phosphate/amylopectin paste combined with recombinant human transforming growth factor beta 1 as a bone defect filler. , 1997, Journal of biomedical materials research.

[24]  J. Klein-Nulend,et al.  Transforming growth factor-beta1 incorporated in calcium phosphate cement stimulates osteotransductivity in rat calvarial bone defects. , 2001, Clinical oral implants research.

[25]  C. Bosch,et al.  Recombinant Transforming Growth Factor‐β1 Induces Endochondral Bone in the Baboon and Synergizes with Recombinant Osteogenic Protein‐1 (Bone Morphogenetic Protein‐7) to Initiate Rapid Bone Formation , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  W. Border,et al.  Transforming growth factor-beta in glomerular injury. , 1994, Experimental nephrology.

[27]  J. Jansen,et al.  Ectopic bone formation in titanium mesh loaded with bone morphogenetic protein and coated with calcium phosphate. , 2001, Plastic and reconstructive surgery.

[28]  P. Speight,et al.  Effect of poly DL-lactide--co-glycolide implants and xenogeneic bone matrix-derived growth factors on calvarial bone repair in the rabbit. , 1994, Biomaterials.

[29]  J. Heckman,et al.  Bone morphogenetic protein but not transforming growth factor-beta enhances bone formation in canine diaphyseal nonunions implanted with a biodegradable composite polymer. , 1999, The Journal of bone and joint surgery. American volume.

[30]  A. Tencer,et al.  TGF-beta 1 forms functionally normal bone in a segmental sheep tibial diaphyseal defect. , 1996, The Journal of otolaryngology.

[31]  J. Galante,et al.  Enhancement of bone ingrowth by transforming growth factor-beta. , 1995, The Journal of bone and joint surgery. American volume.

[32]  Y. Lu,et al.  Role of transforming growth factor beta (TGF-beta) in repairing of bone defects. , 1996, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[33]  R. Hammer,et al.  Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice. , 1997, The Journal of clinical investigation.

[34]  P. Calabresi,et al.  Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS , 1998, Neurology.

[35]  W. Border,et al.  Transforming Growth Factor β in Tissue Fibrosis , 1994 .

[36]  J. Jansen,et al.  Application of magnetron sputtering for producing ceramic coatings on implant materials. , 1993, Clinical oral implants research.

[37]  A. Linde,et al.  Opposite effects of recombinant human transforming growth factor-beta 1 on bone regeneration in vivo: effects of exclusion of periosteal cells by microporous membrane. , 1998, Bone.

[38]  S. Ledbetter,et al.  Renal fibrosis in mice treated with human recombinant transforming growth factor-beta2. , 2000, Kidney international.